Effectiveness and safety of bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with ST-elevation myocardial infarction

被引：0
|
作者：
Filipa Melao, F. [1 ]
Ribeiro, V. [1 ]
Rodrigues, R. [1 ]
Lopes, R. [1 ]
Pereira, M. [2 ]
Silva, J. C. [1 ]
Maciel, M. J. [1 ]
机构：
[1] Ctr Hosp Sao Joao, Oporto, Portugal
[2] Univ Porto, Sch Med, Dept Hyg & Epidemiol, P-4100 Oporto, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1582
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF BIVALIRUDIN VERSUS HEPARIN PLUS GLYCOPROTEIN IIB/IIIA INHIBITOR IN THE TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION-A HORIZONS TRIAL ANALYSIS USING UK VALUATIONS
    Schwenkglenks, M.
    Szucs, T. D.
    Brazier, J. E.
    Blackman, D. J.
    Cyr, P.
    Olchanski, N.
    Stone, G. W.
    VALUE IN HEALTH, 2009, 12 (07) : A334 - A335
  • [22] Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report
    Grimfjard, Per
    Erlinge, David
    Koul, Sasha
    Lagerqvist, Bo
    Svennblad, Bodil
    Varenhorst, Christoph
    James, Stefan
    AMERICAN HEART JOURNAL, 2016, 176 : 78 - 82
  • [23] Abciximab and Heparin versus Bivalirudin for Non-ST-Elevation Myocardial Infarction
    Kastrati, Adnan
    Neumann, Franz-Josef
    Schulz, Stefanie
    Massberg, Steffen
    Byrne, Robert A.
    Ferenc, Miroslaw
    Laugwitz, Karl-Ludwig
    Pache, Juergen
    Ott, Ilka
    Hausleiter, Joerg
    Seyfarth, Melchior
    Gick, Michael
    Antoniucci, David
    Schoemig, Albert
    Berger, Peter B.
    Mehilli, Julinda
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (21): : 1980 - 1989
  • [24] Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction
    South China Journal of Cardiology, 2011, (04) : 268 - 268
  • [25] Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes
    Schwenkglenks, Matthias
    Brazier, John E.
    Szucs, Thomas D.
    Fox, Keith A. A.
    VALUE IN HEALTH, 2011, 14 (01) : 24 - 33
  • [26] Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction
    James, Stefan
    Koul, Sasha
    Andersson, Jonas
    Angeras, Oskar
    Bhiladvala, Pallonji
    Calais, Fredrik
    Danielewicz, Mikael
    Frobert, Ole
    Grimfjard, Per
    Gotberg, Matthias
    Henareh, Loghman
    Ioanes, Dan
    Jensen, Jens
    Linder, Rikard
    Lindroos, Pontus
    Omerovic, Elmir
    Panayi, Georgios
    Ramunddal, Truls
    Sarno, Giovanna
    Ulvenstam, Anders
    Voltz, Sebastian
    Wagner, Henrik
    Wikstrom, Helena
    Ostlund, Ollie
    Erlinge, David
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (12) : E008969
  • [27] Economic evaluation of bivalirudin with or without glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for early invasive management of acute coronary syndromes
    Pinto, Duane S.
    Stone, Gregg W.
    York, Meghan
    Reynolds, Matthew R.
    McLaurin, Brent T.
    Cox, David A.
    Schneider, Elizabeth A.
    Shi, Chunxue
    Walczak, Joshua
    Vachon, David A.
    Berezin, Ronna H.
    Meman, Roxana
    Orman, E. Magnus
    Lincoff, A. Michael
    Cohen, David J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A219 - A219
  • [28] Economic Evaluation of Bivalirudin With or Without Glycoprotein IIb/IIIa Inhibition Versus Heparin With Routine Glycoprotein IIb/IIIa Inhibition for Early Invasive Management of Acute Coronary Syndromes
    Pinto, Duane S.
    Stone, Gregg W.
    Shi, Chunxue
    Dunn, Elizabeth S.
    Reynolds, Matthew R.
    York, Meghan
    Walczak, Joshua
    Berezin, Ronna H.
    Mehran, Roxana
    McLaurin, Brent T.
    Cox, David A.
    Ohman, E. Magnus
    Lincoff, A. Michael
    Cohen, David J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (22) : 1758 - 1768
  • [29] Glycoprotein IIB/IIIA inhibition in acute myocardial infarction
    Tan, Huay Cheem
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 6 - 7
  • [30] Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction
    Dobesh, PP
    Kasiar, JB
    PHARMACOTHERAPY, 2002, 22 (07): : 864 - 888
12345